Saturday 17 October 2026
Export BRSHF’s income statement to Excel — free account
Bruush Oral Care Inc.
BRSHF Consumer Defensive Household & Personal Products
Revenue growth for five consecutive years.
0.00
0.00
NaN
Follow BRSHF
| Dec '22 | Oct '22 | Oct '21 | Oct '20 | |
|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 5.24 | 0.00 | 0.00 |
P/FCF ratio |
— | 1.32 | 68.96 | 68.96 |
Altman Z″-Score (non-manufacturers) |
— | — | (72.21) | (62.63) |
P/Operating CF |
— | 2.64 | 20,962.50 | 20,962.50 |
P/B ratio |
— | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 7.83 | 0.00 | 0.00 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | 1.97 | 102.23 | 102.23 |
EV/FCF |
— | 1.97 | 105.60 | 105.60 |
Quick Ratio |
0.10 | 0.10 | 0.41 | 0.27 |
Current Ratio |
0.46 | 0.46 | 1.08 | 1.12 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.08 | (0.21) |
Debt/Assets |
0.00% | 0.00% | 0.85% | 87.89% |
Debt/Equity |
0.00 | 0.00 | 0.11 | (2.00) |
Asset Turnover |
0.00 | 0.00 | 0.70 | 0.00 |
Operating CF/Net income |
0.00 | 0.00 | 0.46 | 1.06 |
Capex/Depreciation |
0.00 | 0.00 | — | — |
Interest Coverage |
— | — | (880.61) | (160.32) |
| 0.00% | 0.00% | 33,049.81% | 0.00% | |
| 0.00% | 0.00% | (693.10%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | (5,450.89%) | (1,622.24%) |
Average Days of Receivables |
0.00 | 0.00 | 32.89 | 22.88 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 355.13% | 392.43% | 637.85% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | (0.16) | 0.06 | 0.06 |
Graham Number |
— | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (485.60%) | (485.60%) | (485.60%) |
Free Cash Flow Yield |
— | 75.70% | 1.45% | 1.45% |
Revenue per Share |
— | 13.71 | 3.07 | 0.71 |
Operating CF per Share |
0.00 | 0.00 | (13.80) | (4.97) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | (13.80) | (4.97) |
Cash per Share |
0.00 | 0.00 | 2.36 | 0.62 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.56 | (0.74) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.56 | (0.74) |
Free Cash Flow |
0.00 | 0.00 | (4.05) | (1.46) |
Working Capital |
(1.41) | (1.41) | 0.16 | 0.09 |
Capital Expenditures |
0.00 | 0.00 | 0.00 | — |
Net Current Asset Value |
(1.41) | (1.41) | 0.16 | 0.09 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | — |
Cash ROIC |
0.00% | 0.00% | (464.03%) | (366.92%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 19.13 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 21.57 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 6.01 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 16.20 | 791.04 |
Days of Inventory on Hand |
0.00 | 0.00 | 80.48 | 1,836.04 |
Average Receivables |
0.18 | 0.13 | 0.05 | — |
Average Payables |
1.35 | 0.79 | 0.25 | — |
Average Inventory |
0.24 | 0.71 | 0.89 | — |
Average Assets |
1.19 | 1.63 | 1.28 | — |
Average Common Equity |
(1.40) | (0.62) | (0.03) | — |
Columns are period end dates